Sobi
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Sweden · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Tomtebodavägen 23a, Stockholm, Stockholm...Phone Number
+46 86972000Website
www.sobi.comRevenue
$3 BillionStock Symbol
SOBIIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
6
1
1
1
1
1
About Sobi
Sobi, founded in 2010 and based in Stockholm, Sweden, is an international biopharmaceutical company. Sobi has a research focus on therapies in hematology, immunology, and more.Explore more
Sobi Org Chart
SB
Global Therapeutic Area Myeloid Neoplasms, Me...
SK
Clinical Development Hematology Head
SH
Head Director, Clinical Operationns Head of P...
Ed
Head Executive Director, Clinical Study Manag...
SR
Senior Director, Clinical Operations
JL
Director, Search and Evaluation
PK
Director, Patient Services
IO
Medical Director, Clinical Science
BD
Executive Medical Director, Medical Affairs
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sobi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sobi has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sobi launches new products
Congratulate Masked Content for being promoted to Masked Content at Sobi
Earning: See what the market has to say on Sobi recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Sobi, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Sobi is spiking on competitors!
Click to see if Sobi had a recent Job posting/layoffs
Check if Sobi has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Sobi as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Sobi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sobi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sobi.
Sobi financials insights
Gather financial insights about Sobi, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Stock Offering
$65.4M
2016
Debt
$87.1M
Sobi Tech Stack
A closer look at the technologies used by Sobi
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Product Marketing, Events, Engineering, Research & Development, Contingent Workforce, Sales, Business Development, Outsourcing, Search, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, HR Operations, Manufacturing Operations, Operations, Organizational Development
Hiring Plans
Sobi has more open roles in Finance than it has had at any time in the past 9 months. Areas of expertise include: Due Diligence, Business Development, Business Partnering, International Regulatory Compliance, Outsourcing, Cost Structures, and Lifecycle Management.
Hiring Plans
Hiring Plans
Sobi has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Hiring Plans
Sobi News & Media
Sobi to showcase new data across haemophilia portfolio at ISTH 2026
New analyses and real-world evidence highlight outcomes with Altuvoct®, Elocta® and Alprolix® in haemophilia A and B STOCKHOLM, June 30, 2026 /PRNewswire/ -- Sobi® today announced new data across its haemophilia portfolio will be presented at the 2026 Congress of the International Society...Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
STOCKHOLM, June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical safety or efficacy concerns were identified that impact approvability Sobi to meet with FDA to discuss...Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
STOCKHOLM, June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical safety or efficacy concerns were identified that impact approvability Sobi to meet with FDA to discuss...Sobi to present new clinical and real-world data at EHA 2026 in Stockholm
Sobi's presentations highlight research across multiple rare diseases in haematology including PNH, ITP, HLH and myelofibrosis. STOCKHOLM, June 11, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that new clinical and real-world data will be presented at the 2026 Congress of the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sobi
Sign Up For FreeTo access detailed company insights
Sobi, founded in 2010 and based in Stockholm, Sweden, is an international biopharmaceutical company. Sobi has a research focus on therapies in hematology, immunology, and more.... Read More
